Preskoči na sadržaj
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Napredno
  • Acarbose was effective in main...
  • Citiraj ovo
  • Pošalji tekstualnu poruku
  • Pošalji ovo e-mailom
  • Ispiši
  • Izvezi zapis
    • Izvezi u RefWorks
    • Izvezi u EndNoteWeb
    • Izvezi u EndNote
  • Stalna poveznica
Acarbose was effective in maintaining glycemic control in type 2 diabetes mellitus but was associated with adverse effects

Acarbose was effective in maintaining glycemic control in type 2 diabetes mellitus but was associated with adverse effects

Bibliografski detalji
Glavni autori: Holman, R, Dinneen, S
Format: Journal article
Jezik:English
Izdano: 1999
  • Primjerci
  • Opis
  • Slični predmeti
  • Prikaz za djelatnike knjižnice

Slični predmeti

  • The effect of combination therapy of sulfonylurea, metformin, and acarbose in type 2 diabetes mellitus patients
    od: Tri Murti Andayani,, i dr.
    Izdano: (2009-12-01)
  • A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44)
    od: Holman, R, i dr.
    Izdano: (1999)
  • Effects of the addition of acarbose to insulin and non-insulin regimens in veterans with type 2 diabetes mellitus
    od: Wettergreen SA, i dr.
    Izdano: (2016-12-01)
  • Improved glycemic control by acarbose therapy in hypertensive diabetic patients: effects on blood pressure and hormonal parameters
    od: P. Rosenbaum, i dr.
    Izdano: (2002-08-01)
  • Impact of baseline characteristics on glycemic effects of add‐on saxagliptin or acarbose to metformin therapy: Subgroup analysis of the SMART study in Chinese patients with type 2 diabetes mellitus
    od: Hui Fang, i dr.
    Izdano: (2020-07-01)

Opcije pretrage

  • Povijest pretrage
  • Napredna pretraga

Pronađi više

  • Pregledaj katalog
  • Pregledaj abecednim redom
  • Istraži kanale
  • Rezervacije tečajeva
  • Novi predmeti

Trebaš pomoć?

  • Savjeti za pretragu
  • Upitaj knjižničara
  • Često postavljena pitanja